What is the equity of NeuroMetrix this year?
NeuroMetrix has equity of 20.09 M USD this year.
NeuroMetrix Equity 2024
NeuroMetrix Equity
20.09 M USD
Ticker
NURO
ISIN
US6412558073
WKN
A2PVRC
In 2024, NeuroMetrix's equity was 20.09 M USD, a -13.99% increase from the 23.36 M USD equity in the previous year.
NeuroMetrix Aktienanalyse
What does NeuroMetrix do?
NeuroMetrix Inc is an American company specializing in the development, manufacturing, and marketing of medical devices. It was founded in 1996 by Shai N. Gozani and is based in Waltham, Massachusetts. The company is traded on NASDAQ under the ticker symbol 'NURO'. NeuroMetrix ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing NeuroMetrix's Equity
NeuroMetrix's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding NeuroMetrix's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating NeuroMetrix's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
NeuroMetrix's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in NeuroMetrix’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about NeuroMetrix stock
What was the equity of NeuroMetrix compared to the previous year?
The equity of NeuroMetrix has increased/decreased by -13.99% decreased compared to the previous year.
What impact does a high equity have on investors of NeuroMetrix?
A high equity is advantageous for investors of NeuroMetrix as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of NeuroMetrix?
A low equity can be a risk for investors of NeuroMetrix, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of NeuroMetrix affect the company?
An increase in equity of NeuroMetrix can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of NeuroMetrix affect the company?
A reduction in equity of NeuroMetrix can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of NeuroMetrix?
Some factors that can affect the equity of NeuroMetrix include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of NeuroMetrix so important for investors?
The equity of NeuroMetrix is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can NeuroMetrix take to change the equity?
To change equity, NeuroMetrix can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does NeuroMetrix pay?
Over the past 12 months, NeuroMetrix paid a dividend of 1,728 USD . This corresponds to a dividend yield of about 43,969.47 %. For the coming 12 months, NeuroMetrix is expected to pay a dividend of 0 USD.
What is the dividend yield of NeuroMetrix?
The current dividend yield of NeuroMetrix is 43,969.47 %.
When does NeuroMetrix pay dividends?
NeuroMetrix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of NeuroMetrix?
NeuroMetrix paid dividends every year for the past 0 years.
What is the dividend of NeuroMetrix?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is NeuroMetrix located?
NeuroMetrix is assigned to the 'Health' sector.
Wann musste ich die Aktien von NeuroMetrix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of NeuroMetrix from 4/13/2007 amounting to 0.15 USD, you needed to have the stock in your portfolio before the ex-date on 3/28/2007.
When did NeuroMetrix pay the last dividend?
The last dividend was paid out on 4/13/2007.
What was the dividend of NeuroMetrix in the year 2023?
In the year 2023, NeuroMetrix distributed 0 USD as dividends.
In which currency does NeuroMetrix pay out the dividend?
The dividends of NeuroMetrix are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The NeuroMetrix stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von NeuroMetrix
Our stock analysis for NeuroMetrix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NeuroMetrix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
